-

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

An application will be made to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation of this event. The EACCME is an institution of the European ​Union of Medical Specialists (UEMS): www.uems.net.

American Medical Association (AMA)

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Royal College of Physicians and Surgeons of Canada

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca. 

• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues,

On behalf of the Organizing Committee, we are delighted to welcome you to the 11th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2018) to be held on 14-17 February, 2018 in Vienna, Austria.

The world of diabetes treatment is evolving at a dynamic pace that requires harmonization with research, technical advances and devices innovations. Over the last 10 years, the annual ATTD meeting has become the premier international forum to present and discuss innovative and comprehensive overview of the latest research developments in this field.

The ATTD brings together clinicians, such as diabetologists, endocrinologists as well as pediatricans and family medicine practitioners, scientists, engineers, start-ups, investors, medical corporations, regulators and payers from all over the world who take part in the conference, in order to share knowledge and develop collaborations.

Presentations and discussions will be given by many distinguished faculty in the field, and will include topics such as: glucose sensors, closed-loop systems, artificial pancreas, advisors, devices for diabetic prevention, new insulin analogues and delivery systems and insulin pumps and more.

ATTD2018 promises to be an outstanding scientific meeting and we are delighted to welcome you take part in it, in the exciting and bustling city of Vienna.

Yours sincerely, 

Professor Moshe Phillip | Professor Tadej Battelino

                      Conference Chairpersons

Stephanie  Amiel, UK

S.R. Aravind, India

Katharine Brarnard, UK

Richard  Bergenstal, USA

Barbara Murn Berkopec, Slovenia

Sarah Biester, Germany

Bruce  Bode, USA

Jan  Bolinder, Sweden

Riccardo  Bonfanti, Italy

Marc Breton, USA

Natasa  Bratina, Slovenia

Luis Eduardo Calliari, Brazil

Manoj Chawla, India

Eda Cengiz, USA

Pratik Choudhary, UK

Mark Clements, USA

Claudio  Cobelli, Italy

Selçuk Dağdelen, Turkey

Thomas  Danne, Germany

Eyal  Dassau, USA

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Austria Centre

Bruno-Kreisky-Platz 1, 1220 Wien, Austria 

Tel.: +43 1 260690

https://www.acv.at/index.en.html

Submission Info

Participants interested in presenting an Oral or E-Poster presentation are invited to submit an abstract. All abstracts will undergo peer review by the Abstract Review Committee and may be accepted for Oral Presentation, E-Poster Presentation, Read by Title or rejected.

PRESENTATION TYPES AVAILABLE:

ORAL – refers to abstracts accepted for oral presentation at the podium in dedicated Oral Presentation Sessions. 

E-POSTER -  electronic poster presentation on large screens in the E-Poster Area to be viewed during the Conference.  

E-POSTER DISCUSSION- refers to abstracts accepted for E-Poster Presentation, which will be assigned by the Abstract Review Committee, to be presented on large screens in the E-Poster Area at dedicated E-Poster sessions during break times.

E-Poster presenters who register by the early bird registration deadline will also be eligible to present a paper Poster at the Conference. Additional information will be sent to the submitters in due course.

ATTD 2018 is inviting companies dealing with CLINICAL DECISION SUPPORT SYSTEMS/ADVISORS to submit abstracts to be presented during the meeting. Accepted abstracts will be presented at a special space in the Posters hall in the venue, and presenters will have the opportunity to give a 5-minutes oral introduction of about 4-5 slides in a session dedicated to this topic. 

All accepted abstracts will be published in the peer-reviewed journal Diabetes Technology & Therapeutics, published by Mary Ann Liebert, Inc., Publishers. 

The Journal is indexed in PubMed.

All ATTD 2018 Conference attendees will be given an 'access token' to receive 2 months' free access to the Journal online, including the entire journal archive, and an opportunity to subscribe at a discount.

Abstract submission deadline 2017-10-02

Ella Siman , Kenes Group

Phone: 011-41-22-908-0488

Email: esiman@kenes.com